Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News LNG Energy Group Corp. V.LNGE

Alternate Symbol(s):  V.LNGE.W | LNGNF

LNG Energy Group Corp is a Canada-based company, which is focused on the acquisition and development of natural gas production and exploration assets in Latin America. The Company’s assets include Sinu-San Jacinto-1(SSJN-1), Valle Inferior del Magdelana-41 (VIM-41), Valle Inferior del Magdalena-42 (VIM-42) and Sinu-San Jacinto 3-1(SSJN 3-1). The Company has a 50% working interest in SSJN-1, VIM... see more

Recent & Breaking News (TSXV:LNGE)

MINDCURE Provides Update on Strategic Review

PR Newswire March 16, 2022

MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program

PR Newswire March 2, 2022

MINDCURE Announces Strategic Review

PR Newswire February 10, 2022

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform

PR Newswire February 3, 2022

MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022

PR Newswire January 25, 2022

MINDCURE to Participate in the H.C. Wainwright Bioconnect Conference in January 2022

PR Newswire January 6, 2022

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

PR Newswire December 20, 2021

MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022

PR Newswire December 16, 2021

Virtual Conference for Life Sciences Companies Broadcast Live December 16th

PR Newswire December 14, 2021

MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer

PR Newswire December 14, 2021

Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th

PR Newswire December 9, 2021

MINDCURE to Participate in Upcoming Conferences in December 2021

PR Newswire December 2, 2021

MINDCURE Provides Update on Studies and Clinical Trials

PR Newswire November 4, 2021

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform

PR Newswire October 28, 2021

MINDCURE Announces Participation at Upcoming Events in November 2021

PR Newswire October 27, 2021

MINDCURE Announces Financial Results for the First Quarter of Fiscal 2022

PR Newswire October 26, 2021

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

PR Newswire October 18, 2021

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

PR Newswire October 11, 2021

MINDCURE to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on October 13, 2021

PR Newswire October 7, 2021

MINDCURE Announces Commencement of Trading on the OTCQX Best Market

PR Newswire September 30, 2021